ID   Ma-Mel-42a
AC   CVCL_C572
SY   Ma-Mel_42A; Ma-Mel 4; Ma-Mel-42A
DR   ESTDAB; ESTDAB-140
DR   GEO; GSM109065
DR   Wikidata; Q54903798
RX   PubMed=16827748;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): ESTDAB=ESTDAB-140
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,14
ST   FGA: 19,22
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A178 ! Ma-Mel-42
OI   CVCL_C287 ! Ma-Mel-42b
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
RX   PubMed=16827748; DOI=10.1111/j.1600-0749.2006.00322.x;
RA   Hoek K.S., Schlegel N.C., Brafford P., Sucker A., Ugurel S., Kumar R.,
RA   Weber B.L., Nathanson K.L., Phillips D.J., Herlyn M., Schadendorf D.,
RA   Dummer R.;
RT   "Metastatic potential of melanomas defined by specific gene expression
RT   profiles with no BRAF signature.";
RL   Pigment Cell Res. 19:290-302(2006).
//
RX   PubMed=19340423; DOI=10.1007/s00262-009-0701-z; PMCID=PMC11030131;
RA   Mendez R., Aptsiauri N., Del Campo A., Maleno I., Cabrera T.,
RA   Ruiz-Cabello Osuna F., Garrido F., Garcia-Lora A.;
RT   "HLA and melanoma: multiple alterations in HLA class I and II
RT   expression in human melanoma cell lines from ESTDAB cell bank.";
RL   Cancer Immunol. Immunother. 58:1507-1515(2009).
//
RX   PubMed=23851445; DOI=10.1158/1541-7786.MCR-13-0006;
RA   Dahl C., Christensen C., Jonsson G., Lorentzen A., Skjodt M.L.,
RA   Borg A., Pawelec G., Guldberg P.;
RT   "Mutual exclusivity analysis of genetic and epigenetic drivers in
RT   melanoma identifies a link between p14 ARF and RARbeta signaling.";
RL   Mol. Cancer Res. 11:1166-1178(2013).
//